THE Pfizer-Allergan deal is a travesty. Pfizer, which is based in New York, will move overseas by merging with Allergan, based in Ireland, in a maneuver known as a corporate inversion. The point isn't to find corporate synergy. It is to leave behind our uncompetitive international tax system.Not only is this the largest inversion in history, ...